These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

87 related items for PubMed ID: 1334843

  • 1. Platelet receptor expression on three human megakaryoblast-like cell lines.
    Vittet D, Mathieu MN, Launay JM, Chevillard C.
    Exp Hematol; 1992 Oct; 20(9):1129-34. PubMed ID: 1334843
    [Abstract] [Full Text] [Related]

  • 2. Thrombin inhibits proliferation of the human megakaryoblastic MEG-01 cell line: a possible involvement of a cyclic-AMP dependent mechanism.
    Vittet D, Mathieu MN, Launay JM, Chevillard C.
    J Cell Physiol; 1992 Jan; 150(1):65-75. PubMed ID: 1309828
    [Abstract] [Full Text] [Related]

  • 3. Positive modulation of intracellular Ca2+ levels by adenosine A2b receptors, prostacyclin, and prostaglandin E1 via a cholera toxin-sensitive mechanism in human erythroleukemia cells.
    Feoktistov I, Murray JJ, Biaggioni I.
    Mol Pharmacol; 1994 Jun; 45(6):1160-7. PubMed ID: 8022409
    [Abstract] [Full Text] [Related]

  • 4. Human mesenchymal stem cells support megakaryocyte and pro-platelet formation from CD34(+) hematopoietic progenitor cells.
    Cheng L, Qasba P, Vanguri P, Thiede MA.
    J Cell Physiol; 2000 Jul; 184(1):58-69. PubMed ID: 10825234
    [Abstract] [Full Text] [Related]

  • 5. Expression of protease activated receptor 3 (PAR3) is upregulated by induction of megakaryocyte phenotype in human erythroleukemia (HEL) cells.
    Cupit LD, Schmidt VA, Gnatenko DV, Bahou WF.
    Exp Hematol; 2004 Oct; 32(10):991-9. PubMed ID: 15504554
    [Abstract] [Full Text] [Related]

  • 6. [Expression of cyclin B in megakaryocytes and cells of other hematopoietic lines].
    Gu XF, Allain A, Li L, Cramer EM, Tenza D, Caen JP, Han ZC.
    C R Acad Sci III; 1993 Dec; 316(12):1438-45. PubMed ID: 8087623
    [Abstract] [Full Text] [Related]

  • 7. Cyclic-AMP inhibits cell growth and negatively interacts with platelet membrane glycoprotein expression on the Dami human megakaryoblastic cell line.
    Vittet D, Duperray C, Chevillard C.
    J Cell Physiol; 1995 Jun; 163(3):645-55. PubMed ID: 7539815
    [Abstract] [Full Text] [Related]

  • 8. Genetic manipulation of megakaryocytes to study platelet function.
    Liu J, DeNofrio J, Yuan W, Wang Z, McFadden AW, Parise LV.
    Curr Top Dev Biol; 2008 Jun; 80():311-35. PubMed ID: 17950378
    [Abstract] [Full Text] [Related]

  • 9. A novel strategy for generating platelet-like fragments from megakaryocytic cell lines and human progenitor cells.
    Gandhi MJ, Drachman JG, Reems JA, Thorning D, Lannutti BJ.
    Blood Cells Mol Dis; 2005 Jun; 35(1):70-3. PubMed ID: 15923131
    [Abstract] [Full Text] [Related]

  • 10. Recombinant human megakaryocyte growth and development factor (rHuMGDF), a ligand for c-Mpl, produces functional human platelets in vitro.
    Choi ES, Hokom M, Bartley T, Li YS, Ohashi H, Kato T, Nichol JL, Skrine J, Knudten A, Chen J.
    Stem Cells; 1995 May; 13(3):317-22. PubMed ID: 7542117
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Not Ca2+ but CAMP is the second messenger for morphological changes in rat megakaryocyte.
    Uneyama C, Imazawa T, Uneyama H, Akaike N, Kawanishi T, Takahashi M.
    Biochem Biophys Res Commun; 1995 Jun 06; 211(1):282-8. PubMed ID: 7779097
    [Abstract] [Full Text] [Related]

  • 13. Effect of heparin and dihydroergotamine on platelet adenosine-3',5'-cyclic monophosphate.
    Zahavi M, Welzel D, Wolf H, Honey A, Kakkar VV.
    Arzneimittelforschung; 1987 Jun 06; 37(6):669-74. PubMed ID: 2822055
    [Abstract] [Full Text] [Related]

  • 14. Characterization and transplantation of induced megakaryocytes from hematopoietic stem cells for rapid platelet recovery by a two-step serum-free procedure.
    Chen TW, Hwang SM, Chu IM, Hsu SC, Hsieh TB, Yao CL.
    Exp Hematol; 2009 Nov 06; 37(11):1330-1339.e5. PubMed ID: 19664680
    [Abstract] [Full Text] [Related]

  • 15. Regulation of protease-activated receptor (PAR) 1 and PAR4 signaling in human platelets by compartmentalized cyclic nucleotide actions.
    Bilodeau ML, Hamm HE.
    J Pharmacol Exp Ther; 2007 Aug 06; 322(2):778-88. PubMed ID: 17525299
    [Abstract] [Full Text] [Related]

  • 16. A new insight of anti-platelet effects of sirtinol in platelets aggregation via cyclic AMP phosphodiesterase.
    Liu FC, Liao CH, Chang YW, Liou JT, Day YJ.
    Biochem Pharmacol; 2009 Apr 15; 77(8):1364-73. PubMed ID: 19426675
    [Abstract] [Full Text] [Related]

  • 17. Cytokine mRNA expression in human platelets and a megakaryocytic cell line and cytokine modulation of platelet function.
    Soslau G, Morgan DA, Jaffe JS, Brodsky I, Wang Y.
    Cytokine; 1997 Jun 15; 9(6):405-11. PubMed ID: 9199874
    [Abstract] [Full Text] [Related]

  • 18. Expression of megakaryocytic and erythroid properties in human leukemic cells.
    Tani T, Ylänne J, Virtanen I.
    Exp Hematol; 1996 Feb 15; 24(2):158-68. PubMed ID: 8641337
    [Abstract] [Full Text] [Related]

  • 19. Mechanisms of platelet activation and inhibition.
    Ashby B, Daniel JL, Smith JB.
    Hematol Oncol Clin North Am; 1990 Feb 15; 4(1):1-26. PubMed ID: 2155902
    [Abstract] [Full Text] [Related]

  • 20. A newly established megakaryoblastic/erythroid cell line that differentiates to red cells in the presence of erythropoietin and produces platelet-like particles.
    Tsuyuoka R, Takahashi T, Suzuki A, Sasaki Y, Nakamura K, Fukumoto M, Ohmori K, Ohno Y, Nakao K.
    Stem Cells; 1995 Jan 15; 13(1):54-64. PubMed ID: 7719248
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.